Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies

Circ Heart Fail. 2015 Jul;8(4):826-31. doi: 10.1161/CIRCHEARTFAILURE.115.002271.

¹ From the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (M.V.); Division of Cardiology, Stony Brook University, NY (J.B.); University of Michigan School of Medicine, Ann Arbor (B.P.); and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL (M.G.).
² From the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (M.V.); Division of Cardiology, Stony Brook University, NY (J.B.); University of Michigan School of Medicine, Ann Arbor (B.P.); and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL (M.G.). m-gheorghiade@northwestern.edu.

No abstract available

Keywords: blood pressure; blood pressure measurement/monitoring; heart failure; hypotension; pharmacology.

Publication types